Literature DB >> 12031985

Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.

Helen M Colhoun1, James D Otvos, Mike B Rubens, M R Taskinen, S Richard Underwood, John H Fuller.   

Abstract

Type 1 diabetes is associated with increased coronary atherosclerosis, especially in women, even though such patients often have an apparently normal lipid profile. We examined whether lipoprotein particle sizes and subclasses differed between type 1 diabetic subjects (n = 194, age 30-55 years) and age- and sex-matched control subjects (n = 195). We examined whether any abnormalities were of similar magnitude in men and women. The relationship of particle size to electron beam computer tomography-defined coronary artery calcification, a measure of atherosclerosis, was also examined. Proton nuclear magnetic resonance (NMR) spectroscopy was used to quantify VLDL, LDL, and HDL subclass levels and average particle size on fasting samples. LDL size and subclass were similar in diabetic and nondiabetic men. In contrast, in women diabetes was associated with less large and more small LDL and a reduced LDL size (mean difference 0.2 nm; P = 0.0009). This greater effect of diabetes on LDL size in women compared with men was significant (P = 0.007). Diabetes was associated with more large and less small HDL and, to a similar degree in both sexes, a higher HDL size (difference of 0.4 nm in men and 0.3 nm in women; both P < 0.0001). There were no definitive abnormalities in VLDL size. In nondiabetic subjects, lower average HDL particle size, lower LDL size, and higher VLDL size were significantly associated with coronary calcification (P = 0.001, 0.02, and 0.04, respectively). Thus the HDL size differences with diabetes would be expected to be antiatherogenic and the LDL size differences pro-atherogenic. However, there was no clear relationship between particle size and calcification in diabetic subjects. We conclude that in the general population NMR spectroscopy-derived particle size reveals important information about the atherogenicity of lipoprotein profile. Type 1 diabetes is associated with differences in NMR-derived particle size, but their pathogenic significance is unclear.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031985     DOI: 10.2337/diabetes.51.6.1949

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  51 in total

1.  Lipoprotein subfractions and particle size in end-stage renal disease.

Authors:  Peter A McCullough; Fawaz Al-Ejel; Robert C Maynard
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

2.  Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum.

Authors:  Ville-Petteri Mäkinen; Pasi Soininen; Carol Forsblom; Maija Parkkonen; Petri Ingman; Kimmo Kaski; Per-Henrik Groop; Mika Ala-Korpela
Journal:  MAGMA       Date:  2006-12-15       Impact factor: 2.310

3.  Rat adult offspring serum lipoproteins are altered by maternal consumption of a liquid diet.

Authors:  J S Pennington; S N Pennington
Journal:  Lipids       Date:  2006-04       Impact factor: 1.880

4.  Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.

Authors:  Dan Liao; Hongmei Tan; Rutai Hui; Zhaohui Li; Xiaohua Jiang; John Gaubatz; Fan Yang; William Durante; Lawrence Chan; Andrew I Schafer; Henry J Pownall; Xiaofeng Yang; Hong Wang
Journal:  Circ Res       Date:  2006-08-24       Impact factor: 17.367

5.  Subfractions of High-Density Lipoprotein-Cholesterol and Carotid Intima-Media Thickness: The Northern Manhattan Study.

Authors:  Eduard Tiozzo; Hannah Gardener; Barry I Hudson; Chuanhui Dong; David Della-Morte; Milita Crisby; Ronald B Goldberg; Mitchell S V Elkind; Ying Kuen Cheung; Clinton B Wright; Ralph L Sacco; Moise Desvarieux; Tatjana Rundek
Journal:  Stroke       Date:  2016-05-10       Impact factor: 7.914

Review 6.  The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it.

Authors:  Alicia Jenkins; Andrzej Januszewski; David O'Neal
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

7.  Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy.

Authors:  Monique A Ford; Joseph P McConnell; Shahar Lavi; Charanjit S Rihal; Abhiram Prasad; Gurpreet S Sandhu; Stacy J Hartman; Lilach O Lerman; Amir Lerman
Journal:  Atherosclerosis       Date:  2009-05-06       Impact factor: 5.162

8.  Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance.

Authors:  David M Maahs; John E Hokanson; Hong Wang; Gregory L Kinney; Janet K Snell-Bergeon; Ashley East; Bryan C Bergman; Irene E Schauer; Marian Rewers; Robert H Eckel
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

9.  Association of postprandial hyperglycemia with in vitro LDL oxidation in non-smoking patients with type 1 diabetes--a cross-sectional study.

Authors:  Simone H de Castro; Hugo C Castro-Faria-Neto; Marilia B Gomes
Journal:  Rev Diabet Stud       Date:  2005-11-10

10.  Atomistic simulations of phosphatidylcholines and cholesteryl esters in high-density lipoprotein-sized lipid droplet and trilayer: clues to cholesteryl ester transport and storage.

Authors:  Artturi Koivuniemi; Mikko Heikelä; Petri T Kovanen; Ilpo Vattulainen; Marja T Hyvönen
Journal:  Biophys J       Date:  2009-05-20       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.